Two East Coast pharma companies are adding general counsel to their executive ranks, hiring compliance leaders with deep biotech industry experience to head their legal teams.
Tris Pharma—a New Jersey-based drugmaker focused on treatments for attention deficit hyperactivity disorder, addiction and other neurological diseases—hired Franchesca Fowler as its chief compliance officer and general counsel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]